Vaccines,
Journal Year:
2023,
Volume and Issue:
11(4), P. 766 - 766
Published: March 30, 2023
COVID-19
continues
to
be
a
public
health
concern
in
the
United
States.
Although
safe
and
effective
vaccines
have
been
developed,
significant
proportion
of
US
population
has
not
received
vaccine.
This
cross-sectional
study
aimed
describe
demographics
behaviors
Minnesota
adults
who
primary
series
vaccine,
or
booster
shot
using
data
from
Antibody
Study
(MCAS)
collected
through
population-based
sample
between
September
December
2021.
Data
were
web-based
survey
sent
individuals
that
responded
similar
2020
their
adult
household
members.
The
was
51%
female
86%
White/Non-Hispanic.
A
total
9%
vaccine-eligible
participants
had
23%
those
eligible
receive
it.
Older
age,
higher
education,
better
self-reported
health,
$75,000
$100,000
annual
income,
mask-wearing,
social
distancing
associated
with
lower
odds
hesitancy.
Gender,
race,
previous
infection
most
frequently
reported
reason
for
receiving
vaccination
safety
concerns.
Mask-wearing
being
age
65
older
only
strong
predictors
vaccine
hesitancy
both
analyses.
Journal of Clinical Nursing,
Journal Year:
2022,
Volume and Issue:
32(13-14), P. 3943 - 3953
Published: Nov. 7, 2022
Abstract
Aims
and
objectives
To
assess
the
levels
of
second
COVID‐19
booster
dose/new
vaccine
hesitancy
among
nurses
explore
potential
predictors
hesitancy.
Background
full
vaccination
seems
to
be
highly
effective
against
contagious
variants
SARS‐CoV‐2.
Healthcare
workers
are
at
high‐risk
group
since
they
have
experienced
high
COVID‐19‐associated
morbidity
mortality.
Design
An
on‐line
cross‐sectional
study
was
carried
out
in
Greece
May
2022,
using
a
self‐administered
questionnaire.
Methods
The
population
included
healthcare
services
who
were
fully
vaccinated
time
study.
We
considered
socio‐demographic
characteristics,
COVID‐19‐related
variables,
attitudes
toward
pandemic
as
applied
STROBE
checklist
our
Results
Among
795
nurses,
30.9%
hesitant
dose
or
new
vaccine.
Independent
lower
educational
level,
absence
chronic
condition,
good/very
good
self‐perceived
physical
health,
lack
flu
during
2021,
front‐line
that
provided
patients,
had
not
been
diagnosed
with
least
one
relative/friend
has
died
from
COVID‐19.
Moreover,
increased
compliance
hygiene
measures,
fear
decreased
trust
associated
Conclusions
Our
shows
significant
percentage
This
initial
could
barrier
efforts
control
pandemic.
Relevance
clinical
practice
Nurses'
role
is
essential
empowering
public
their
passion
empathy.
There
need
communicate
science
way
accessible
order
decrease
Patient
contribution
No
patient
contribution.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 392 - 392
Published: Feb. 8, 2023
A
second
COVID-19
vaccine
booster
dose
is
effective
and
safe
for
older
adults.
This
study
investigated
hesitancy
to
take
up
a
its
determinants
among
adults
in
Hong
Kong.
Participants
were
Chinese-speaking
community-dwelling
aged
65
years
or
above.
Telephone
numbers
randomly
selected
from
up-to-date
telephone
directories.
total
of
370
participants
completed
the
survey.
Logistic
regression
models
fitted
data
analysis.
Among
participants,
half
(52.4%)
hesitant
receive
dose.
After
adjustment
significant
background
characteristics,
perceived
benefits
(AOR:
0.50,
95%CI:
0.42,
0.60),
cues
action
0.39,
0.30,
0.52),
self-efficacy
0.37,
0.21,
0.66)
receiving
associated
with
lower
hesitancy.
Perceived
barriers
1.23,
1.12,
1.34)
fatigue
(tired
repeated
vaccination)
1.90,
1.52,
2.38)
higher
Level
was
high
Health
authorities
should
address
modify
perceptions
related
Human Vaccines & Immunotherapeutics,
Journal Year:
2023,
Volume and Issue:
19(1)
Published: Jan. 2, 2023
Coronavirus
disease
2019
(COVID-19)
has
wreaked
havoc
across
the
globe
for
approximately
three
years.
Vaccination
is
a
key
factor
to
ending
this
pandemic,
but
its
protective
effect
diminishes
over
time.
A
second
booster
dose
at
right
time
needed.
To
explore
willingness
receive
fourth
of
COVID-19
vaccine
and
influencing
factors,
we
commenced
national,
cross-sectional
anonymous
survey
in
mainland
China
among
people
aged
18
above
from
October
24
November
7,
2022.
total
3,224
respondents
were
eventually
included.
The
acceptance
rate
was
81.1%
(95%
CI:
79.8–82.5%),
while
it
72.6%
71.1–74.2%)
heterologous
booster.
Confidence
current
domestic
situation
effectiveness
previous
vaccinations,
uncertainty
about
extra
protection
main
reasons
hesitancy.
Perceived
benefit
(aOR
=
1.29,
95%
1.159–1.40)
cues
action
1.73,
1.60–1.88)
positively
associated
with
acceptance,
whereas
perceived
barriers
0.78,
0.72–0.84)
self-efficacy
0.79,
0.71–0.89)
both
negatively
it.
Additionally,
sex,
age,
vaccination
history,
social
media,
satisfaction
government's
response
also
factors
affecting
intention.
Factors
intention
similar
results.
It
profound
theoretical
practical
significance
clarify
population's
vaccinate
advance
relevant
subsequent
development
promotion
fourth-dose
strategies.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 331 - 331
Published: Feb. 1, 2023
High-risk
populations
are
at
increased
risk
of
severe
influenza-related
illness,
hospitalization,
and
death
due
to
influenza.
The
aim
our
study
was
assess
the
willingness
high-risk
take
influenza
vaccine
for
2022-2023
season,
investigate
factors
associated
with
such
willingness.
We
conducted
a
cross-sectional
in
Greece
September
2022
using
convenience
sample.
considered
demographic
characteristics,
COVID-19-related
variables,
resilience,
social
support,
anxiety,
depression,
burnout
as
potential
predictors.
Among
participants,
39.4%
were
willing
accept
seasonal
vaccine,
33.9%
unwilling,
26.8%
hesitant.
Multivariable
analysis
identified
that
age
family
support
vaccination
Moreover,
participants
have
received
COVID-19
booster
doses
more
vaccine.
In
contrast,
adverse
effects
because
exhaustion
measures
against
reduced
found
intention
receive
low.
Our
contributes
an
understanding
affect
Public
health
authorities
could
use
this
information
update
programs
Emphasis
should
be
given
on
safety
effectiveness
issues.
Vaccine X,
Journal Year:
2024,
Volume and Issue:
18, P. 100480 - 100480
Published: March 23, 2024
The
global
deployment
of
COVID-19
vaccine
booster
dose
(VBD)
has
been
recognized
as
a
promising
therapeutic
alliance
to
provide
repeated
immunity
against
the
arrival
new
variants.
Despite
scientific
evidence
supports
effectiveness
periodic
doses,
reluctance
continues
thrive.
This
narrative
review
aimed
examine
doses
acceptance
and
summarize
an
up-to-date
assessment
potential
antecedents
associated
with
VBD
acceptance.
A
comprehensive
search
was
performed
in
several
reputable
databases
such
Medline
(via
PubMed),
Scopus,
Google
scholar,
Web
Science
from
June
10th,
2023,
August
1st,
2023.
All
relevant
descriptive
observational
studies
on
hesitancy
were
included
this
review.
total
fifty-eight
(58)
included,
Asia
representing
highest
count
thirty-one
(53
%)
studies,
Europe
eleven
(19
%),
United
States
nine
(16
other
regions
(Africa
multi-ethnic)
seven
(12
%).
Worldwide,
pooled
rate
77.09
%
(95
CI:
76.28–78.18),
willingness
(n)
=
164189,
sample
(N)
212,990.
lowest
reported
American
regions,
respectively,
85.38
85.02–85.73,
32,047,
(N
37,533)
vs.
66.92
66.56–67.4),
29335,
43,832.
However,
multi-ethnic
areas
moderately
high
79.13
78.77–79.23,
93,994,
11,8779)
72.16
71.13–72.93,
9276,
12,853),
respectively.
most
common
key
across
countries
"equal
safety",
"efficacy",
"effectiveness",
post-vaccination
"side
effects",
"community
protection"
"family
protection",
"risk-benefit
ratio",
necessity",
"trust,
"variants
control".
Disparities
uptake
observed
globally,
rates
found
Europe,
regions.
Multiple
including
safety,
efficacy,
side
effects
hesitancy.
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(1), P. 159 - 159
Published: Jan. 11, 2023
Seasonal
influenza
continues
to
be
a
significant
public
health
issue
causing
hundreds
of
thousands
deaths
annually.
Nurses
are
priority
risk
group
for
vaccination
and
high
vaccine
uptake
rate
among
them
is
crucial
protect
health.
Thus,
the
aim
our
study
was
estimate
levels
acceptance,
as
well
its
determinants,
nurses
2022/2023
season.
We
conducted
cross-sectional
with
convenience
sample
in
Greece.
collected
data
via
an
online
survey
September
2022.
Most
possessed
MSc/PhD
diploma
(56.2%)
had
previously
been
infected
by
SARS-CoV-2
(70.3%).
Among
nurses,
57.3%
were
willing
accept
vaccine,
19%
hesitant,
23.7%
unwilling.
Older
age,
higher
perceived
support
from
others,
COVID-19-related
physical
exhaustion
positively
related
intention.
In
contrast,
more
side
effects
because
COVID-19
due
measures
taken
against
negatively
associated
Since
acceptance
moderate,
policymakers
should
develop
implement
tailored
specifically
context
pandemic
decrease
hesitancy.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(6), P. 602 - 602
Published: May 31, 2024
The
decision
to
vaccinate
against
COVID-19
is
primarily
a
personal
choice
influenced
by
numerous
factors.
Vaccine
acceptance
and
positive
attitude
towards
vaccination
among
nurses
have
an
impact
on
patients’
willingness
vaccinate.
To
assess
coverage
primary
healthcare
associate
socio-demographic
factors,
comorbidity,
self-rated
health,
unhealthy
lifestyle
with
the
be
vaccinated,
we
conducted
online
cross-sectional
study
from
March
May
2023
using
self-administrated
questionnaire.
Probability
sampling
was
used
select
32
health
centers
were
invited
via
email.
Among
560
participants
who
completed
survey,
78.3%
50.8%
received
two-dose
course
at
least
one
booster
dose
of
vaccine,
respectively.
Primary
care
≥41
years
age,
physically
less
active,
those
overweight
opted
statistically
significantly
more
often
for
scheme
(p
=
0.00,
0.015
0.017,
respectively).
Education
living
environments
did
not
influence
receive
two
doses.
Likewise,
good
comorbidity
contribute
decision.
Nurses
that
vaccinated
doses
0.034)
year
age
0.000).
BMC Health Services Research,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 6, 2025
Despite
completing
the
COVID-19
vaccination
series,
healthcare
workers
(HCWs)
remain
at
an
elevated
risk
of
re-infection.
Booster
uptake,
though
essential
for
this
group,
remains
poorly
characterized
among
Bangladeshi
HCWs.
This
study
identified
prevalence
and
driving
factors
behind
booster
hesitancy
HCWs,
providing
valuable
insights
targeted
interventions.
From
December
2022
to
June
2023,
we
conducted
a
cross-sectional
survey
1772
HCWs
enrolled
from
20
facilities
all
tiers
purposively
selected
across
four
administrative
divisions
Bangladesh.
We
collected
information
through
face-to-face
interviews
regarding
their
sociodemographic,
pre-existing,
currently
existing
medical
conditions,
status,
intention,
hesitancy,
willingness
receive
future
doses.
used
multivariable
logistic
regression
model
analyze
associated
with
hesitancy.
Odd's
ratio
95%
confidence
intervals
(CIs)
was
calculated
each
factor,
p
<
0.05
considered
statistically
significant.
Of
interviewed
in
our
study,
49%
(879)
were
nurses
[median
age
36
years
(IQR:
30.0-46.0)];
69%
female.
Among
respondents,
94%
(1667)
willing
take
booster,
6%
(105)
showed
Safety
concerns,
especially
potential
side
effects
post-booster
administration
(86%),
emerged
as
leading
cause
workers.
Our
analysis
revealed
that
support
staff,
compared
physicians,
most
hesitant
any
additional
dose
(aOR
4.68,
CI:
1.56-9.03;
p=0.006).
Compared
rural
residency,
urban
residency
type
also
more
reluctant
doses
4.45,
2.03-9.73;
0.001).
Concerns
about
following
primary
driver
study.
Targeted
interventions
focusing
on
education
addressing
these
anxieties-supported
by
evidence-based
communication
strategies-could
play
crucial
role
improving
acceptance
safeguarding
vulnerable
workforce.
Influenza and Other Respiratory Viruses,
Journal Year:
2025,
Volume and Issue:
19(3)
Published: March 1, 2025
Influenza
vaccination
is
recommended
annually
based
on
the
evolving
nature
of
influenza
viruses
and
waning
vaccine-induced
immunity.
The
timing
usually
before
winter
season
in
most
temperate
locations,
where
seasonality
clear
activities
average
last
no
longer
than
6
months.
However,
many
tropical
subtropical
areas
have
year-round
activity
multiple
epidemics
within
1
year,
against
which
annual
may
not
offer
sufficient
protection
at
individual
level.
A
twice-annual
program
could
utilize
standard
inactivated
vaccines
or
enhanced
vaccines.
Here,
we
discuss
three
reasons
to
consider
as
a
strategy
improve
protection.
first,
mentioned
above,
that
some
locations
experience
prolonged
activity.
second
reason
observation
vaccine
effectiveness
significantly
declines
about
months
after
particularly
for
A(H3N2)
strains,
therefore,
twice
year
might
be
beneficial
maintain
higher
level
immunity
half
each
year.
third
allow
receipt
updated
given
these
are
by
World
Health
Organization.
We
also
potential
barriers
challenges.
first
challenge
knowledge
gaps,
because
there
very
few
existing
studies
used
vaccination.
barrier
concern
over
whether
more
frequent
would
lead
reduced
immunogenicity
clinical
term.
relates
concerns
cost
feasibility.
issues
recommend
comparative
assessment
incremental
benefits
versus
vaccination,
well
other
strategies
aiming
reduce
disease
burden
can
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 273 - 273
Published: Jan. 27, 2023
Vaccine
hesitancy
and
conspiracy
beliefs
among
healthcare
workers
(HCWs)
represent
operational
priorities
that
require
urgent
attention.
Identifying
classifying
specific
subpopulation
of
is
crucial
to
customize
educational
intervention
strategies
enhance
the
acceptance
uptake
rate
vaccination.
Thus,
main
purpose
our
study
was
empirically
identify
latent
profiles
vaccine
Italian
HCWs
adopting
a
person-centered
approach
investigating
their
relationships
with
antecedents
intention
get
fourth
dose
COVID-19
vaccine.
We
conducted
profile
analyses
(LPA)
different
configurations
based
on
five
vaccination:
confidence,
complacency,
constraints,
calculation,
collective
responsibility
sample
(n
=
573).
LPA
revealed
four
distinct
profiles:
believer
(61.5%),
middler
(24.7%),
hesitant
(9.00%),
rejecter
(4.7%).
Having
associated
greater
likelihood
membership
in
all
but
believer.
Finally,
lowest
rejector
profiles.
Theoretical
contributions
implications
for
practice
are
discussed.